EMP3 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	40 studies	60% ± 20%	Explore
macrophage	38 studies	55% ± 23%	Explore
CD8-positive, alpha-beta T cell	38 studies	55% ± 18%	Explore
B cell	37 studies	51% ± 17%	Explore
fibroblast	37 studies	53% ± 17%	Explore
CD4-positive, alpha-beta T cell	34 studies	56% ± 22%	Explore
T cell	33 studies	49% ± 19%	Explore
conventional dendritic cell	29 studies	66% ± 21%	Explore
classical monocyte	27 studies	81% ± 12%	Explore
regulatory T cell	27 studies	59% ± 22%	Explore
mast cell	26 studies	63% ± 20%	Explore
endothelial cell	26 studies	30% ± 13%	Explore
monocyte	25 studies	66% ± 23%	Explore
pericyte	25 studies	38% ± 15%	Explore
smooth muscle cell	25 studies	39% ± 17%	Explore
non-classical monocyte	24 studies	88% ± 11%	Explore
dendritic cell	23 studies	60% ± 25%	Explore
plasmacytoid dendritic cell	22 studies	51% ± 15%	Explore
plasma cell	21 studies	55% ± 18%	Explore
mature NK T cell	20 studies	61% ± 16%	Explore
memory B cell	20 studies	55% ± 20%	Explore
naive B cell	19 studies	41% ± 17%	Explore
connective tissue cell	18 studies	56% ± 18%	Explore
gamma-delta T cell	16 studies	59% ± 20%	Explore
mucosal invariant T cell	16 studies	60% ± 19%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	16 studies	57% ± 13%	Explore
CD16-negative, CD56-bright natural killer cell, human	15 studies	53% ± 22%	Explore
CD16-positive, CD56-dim natural killer cell, human	15 studies	67% ± 18%	Explore
myeloid cell	14 studies	61% ± 21%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	13 studies	63% ± 15%	Explore
myofibroblast cell	13 studies	51% ± 16%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	56% ± 22%	Explore
endothelial cell of artery	12 studies	39% ± 15%	Explore
basal cell	12 studies	20% ± 5%	Explore
effector memory CD8-positive, alpha-beta T cell	11 studies	59% ± 19%	Explore
plasmablast	11 studies	62% ± 24%	Explore
neutrophil	11 studies	53% ± 26%	Explore
CD4-positive, alpha-beta memory T cell	11 studies	66% ± 22%	Explore
mesothelial cell	11 studies	50% ± 23%	Explore
platelet	10 studies	48% ± 23%	Explore
capillary endothelial cell	10 studies	37% ± 12%	Explore
innate lymphoid cell	9 studies	62% ± 23%	Explore
leukocyte	8 studies	56% ± 13%	Explore
IgG plasma cell	8 studies	35% ± 19%	Explore
vein endothelial cell	8 studies	31% ± 22%	Explore
alveolar macrophage	7 studies	57% ± 24%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	74% ± 23%	Explore
IgA plasma cell	7 studies	42% ± 22%	Explore
CD4-positive helper T cell	6 studies	52% ± 14%	Explore
effector CD4-positive, alpha-beta T cell	6 studies	77% ± 22%	Explore
mononuclear phagocyte	6 studies	63% ± 20%	Explore
abnormal cell	6 studies	49% ± 22%	Explore
hematopoietic stem cell	6 studies	49% ± 14%	Explore
intermediate monocyte	6 studies	79% ± 20%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	77% ± 15%	Explore
erythrocyte	6 studies	45% ± 14%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	72% ± 13%	Explore
hematopoietic precursor cell	5 studies	54% ± 8%	Explore
exhausted T cell	5 studies	63% ± 19%	Explore
monocyte-derived dendritic cell	5 studies	68% ± 23%	Explore
erythroblast	5 studies	36% ± 12%	Explore
epithelial cell	5 studies	29% ± 6%	Explore
T-helper 17 cell	5 studies	61% ± 27%	Explore
endothelial cell of vascular tree	5 studies	28% ± 8%	Explore
granulocyte	5 studies	77% ± 20%	Explore
melanocyte	5 studies	69% ± 24%	Explore
CD4-positive, alpha-beta cytotoxic T cell	4 studies	56% ± 32%	Explore
central memory CD8-positive, alpha-beta T cell	4 studies	70% ± 13%	Explore
precursor B cell	4 studies	32% ± 10%	Explore
immature B cell	4 studies	53% ± 11%	Explore
adventitial cell	4 studies	63% ± 11%	Explore
glial cell	4 studies	29% ± 10%	Explore
T follicular helper cell	4 studies	42% ± 18%	Explore
double negative thymocyte	4 studies	62% ± 22%	Explore
Langerhans cell	3 studies	60% ± 18%	Explore
glomerular endothelial cell	3 studies	29% ± 2%	Explore
progenitor cell	3 studies	49% ± 9%	Explore
megakaryocyte	3 studies	65% ± 11%	Explore
microglial cell	3 studies	31% ± 17%	Explore
tissue-resident macrophage	3 studies	44% ± 16%	Explore
ciliated cell	3 studies	18% ± 2%	Explore
muscle cell	3 studies	30% ± 14%	Explore
inflammatory macrophage	3 studies	45% ± 7%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	70% ± 28%	Explore
T-helper 1 cell	3 studies	79% ± 17%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	80% ± 5%	Explore
double-positive, alpha-beta thymocyte	3 studies	60% ± 27%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	20 studies	67% ± 16%	Explore
lung	17 studies	41% ± 17%	Explore
intestine	9 studies	35% ± 12%	Explore
liver	7 studies	37% ± 15%	Explore
bone marrow	6 studies	40% ± 22%	Explore
kidney	5 studies	40% ± 13%	Explore
lymph node	5 studies	44% ± 13%	Explore
uterus	5 studies	39% ± 13%	Explore
placenta	4 studies	28% ± 12%	Explore
skin	4 studies	38% ± 16%	Explore
breast	4 studies	26% ± 5%	Explore
ovary	3 studies	24% ± 1%	Explore
adrenal gland	3 studies	29% ± 11%	Explore
prostate	3 studies	21% ± 3%	Explore
brain	3 studies	29% ± 6%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
skin	97%	4151.55	1752 / 1809	100%	449.97	472 / 472
lung	100%	4750.22	577 / 578	93%	68.73	1079 / 1155
uterus	100%	5033.01	170 / 170	93%	97.83	425 / 459
thymus	94%	1455.09	615 / 653	98%	105.77	590 / 605
breast	97%	2127.80	445 / 459	93%	60.53	1042 / 1118
ovary	100%	3271.41	180 / 180	87%	46.26	375 / 430
kidney	89%	1394.97	79 / 89	92%	110.55	828 / 901
adrenal gland	100%	2694.44	257 / 258	76%	76.21	175 / 230
intestine	98%	3872.22	943 / 966	76%	43.25	402 / 527
bladder	100%	4001.90	21 / 21	72%	55.43	361 / 504
esophagus	82%	2558.55	1181 / 1445	73%	41.83	134 / 183
prostate	96%	2023.09	236 / 245	58%	20.42	292 / 502
stomach	67%	1683.55	241 / 359	83%	49.27	237 / 286
eye	0%	0	0 / 0	100%	153.00	80 / 80
lymph node	0%	0	0 / 0	100%	133.81	29 / 29
peripheral blood	100%	8331.47	929 / 929	0%	0	0 / 0
spleen	100%	3017.81	241 / 241	0%	0	0 / 0
blood vessel	100%	3627.60	1331 / 1335	0%	0	0 / 0
adipose	100%	3403.82	1199 / 1204	0%	0	0 / 0
pancreas	7%	62.08	23 / 328	92%	101.55	164 / 178
tonsil	0%	0	0 / 0	98%	74.83	44 / 45
heart	95%	1858.91	819 / 861	0%	0	0 / 0
brain	32%	330.22	855 / 2642	45%	86.32	314 / 705
liver	9%	102.46	21 / 226	38%	19.45	153 / 406
muscle	10%	92.00	83 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

IV. Literature review

[source]

Gene name	EMP3
Protein name	Epithelial membrane protein 3 Epithelial membrane protein 3 (EMP-3) (Hematopoietic neural membrane protein 1) (HNMP-1) (Protein YMP)
Synonyms	YMP
Description	FUNCTION: Probably involved in cell proliferation and cell-cell interactions. FUNCTION: Probably involved in cell proliferation and cell-cell interactions. . FUNCTION: Probably involved in cell proliferation and cell-cell interactions. .
Accessions	M0QXS0 ENST00000594198.1 M0R1L9 M0QZ66 ENST00000596315.5 ENST00000270221.11 P54852 M0R122 ENST00000593437.1 Q6IBD3 ENST00000597279.5 ENST00000599255.5 ENST00000599704.5 M0QXN1

GO_0006915	Biological process	apoptotic process
GO_0032060	Biological process	bleb assembly
GO_0005886	Cellular component	plasma membrane
GO_0005515	Molecular function	protein binding

EMP3 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review